Literature DB >> 469939

Oxygen binding to sickle cell hemoglobin.

S J Gill, R C Benedict, L Fall, R Spokane, J Wyman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 469939     DOI： 10.1016/0022-2836(79)90425-x

Source DB:  PubMed          Journal:  J Mol Biol        ISSN： 0022-2836            Impact factor:   5.469


× No keyword cloud information.
  7 in total

1.  Probing the energetics of proteins through structural perturbation: sites of regulatory energy in human hemoglobin.

Authors:  D W Pettigrew; P H Romeo; A Tsapis; J Thillet; M L Smith; B W Turner; G K Ackers
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

2.  Ligand-linked phase changes in a biological system: applications to sickle cell hemoglobin.

Authors:  J Wyman; S J Gill
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

3.  Monomer diffusion into polymer domains in sickle hemoglobin.

Authors:  M R Cho; F A Ferrone
Journal:  Biophys J       Date:  1990-10       Impact factor: 4.033

4.  Potential use of biaromatic L-phenylalanyl derivatives as therapeutic agents in the treatment of sickle cell disease.

Authors:  J R Votano; J Altman; M Wilchek; M Gorecki; A Rich
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

5.  Treatment of sickle cell disease by increasing oxygen affinity of hemoglobin.

Authors:  Eric R Henry; Belhu Metaferia; Quan Li; Julia Harper; Robert B Best; Kristen E Glass; Troy Cellmer; Emily B Dunkelberger; Anna Conrey; Swee Lay Thein; H Franklin Bunn; William A Eaton
Journal:  Blood       Date:  2021-09-30       Impact factor: 25.476

6.  MWC allosteric model explains unusual hemoglobin-oxygen binding curves from sickle cell drug binding.

Authors:  Eric R Henry; Julia Harper; Kristen E Glass; Belhu Metaferia; John M Louis; William A Eaton
Journal:  Biophys J       Date:  2021-04-29       Impact factor: 3.699

Review 7.  Impact of hemoglobin biophysical studies on molecular pathogenesis and drug therapy for sickle cell disease.

Authors:  William A Eaton
Journal:  Mol Aspects Med       Date:  2021-07-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.